Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2003
11/12/2003CN1455678A Methods of therapy with thrombin derived peptides
11/12/2003CN1455669A Esmolol formulation
11/12/2003CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
11/12/2003CN1455666A Externally-applicated chewing gum including chip-like center
11/12/2003CN1455662A Dental care compositions
11/12/2003CN1454656A Medicine for curing leuconychia and hand-foot ringworm and preparing method thereof
11/12/2003CN1454527A Anti-fatigue oral liquor
11/12/2003CN1127513C Phosphonic acid derivatives with metallopeptidase inhibitory activity
11/12/2003CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/12/2003CN1127506C New compound for treating asgnodia
11/12/2003CN1127502C Salts of paroxetine
11/12/2003CN1127499C Novel form of irbesartan, Methods of obtaining said form and pharmaceutical compositions containing same
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/12/2003CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646129 Cyanoguanidines as cell proliferation inhibitors
11/11/2003US6646120 Polysaccharides with side chains of methylcarboxylate, carboxymethylbenzylamide, sulfate and sulfonate groups; use as anti-thrombotic, substitute for plasma and modulator of cell proliferation
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
11/11/2003US6645985 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them, and method of treating
11/11/2003US6645981 Antimicrobial quinolones, their compositions and uses
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645975 Process for the preparation of dinaposoline
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645972 Administering nucleoside analogues such as beta-L-dioxolane cytidine as tyrosine kinase inhibitors or anticarcinogenic agents
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645950 Benzimidazole vascular damaging agents
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645740 Nucleic acids encodings equine GM-CSF
11/11/2003US6645533 ATP synthesis activator containing a mixture of herbs
11/11/2003US6645522 Erythropoietin or derivatives that cause bone marrow cells to increase production of reticulocytes and erythrocytes; hydrogenated lecithin that may be hydrogenated; cholesterol or a derivative; phosphate buffer
11/11/2003US6645513 Treatment of skin with adenosine or adenosine analog
11/11/2003US6645509 Treating the thinning of the epidermis with said polypeptide
11/11/2003US6645497 Polynucleotide compositions encoding broad-spectrum δ endotoxins
11/11/2003US6645493 Composition containing anti-MIF antibody
11/11/2003US6645466 Dry powder for inhalation
11/11/2003CA2292497C Dietary compositions for enhancing metabolism and alleviating oxidative stress
11/11/2003CA2290332C Optically pure androgen mediator
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/11/2003CA2264745C Method of inhibiting biosynthesis of eif5a
11/11/2003CA2264569C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
11/11/2003CA2262086C Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
11/11/2003CA2144967C Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/11/2003CA2143756C N-cyano-n'-pyridylguanidines as serotonin antagonists
11/11/2003CA2113424C Muscarinic agonists
11/11/2003CA2091440C 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha adrenergic agents
11/11/2003CA2055637C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
11/06/2003WO2003091728A1 Screening method
11/06/2003WO2003091449A1 Method of measuring neprilysin activity
11/06/2003WO2003091442A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091282A1 Histamine receptor h3 ordinary activity mutant and utilization thereof
11/06/2003WO2003091274A2 Use of alpha-s2 casein precursor-derived peptided
11/06/2003WO2003091272A1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091256A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091245A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism
11/06/2003WO2003091242A1 Novel thiol derivative, process for producing the same and use thereof
11/06/2003WO2003091239A1 Estrogen receptor modulators
11/06/2003WO2003091237A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003091236A1 Imidazolinylmethyl aralkylsulfonamides
11/06/2003WO2003091234A1 Biguanide derivative and therapeutic agent for diabetes containing the same
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091226A1 Triazole derivatives as tachykinin receptor antagonists
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003091219A1 Isoquinoline derivatives
11/06/2003WO2003091216A1 Novel piperidine derivative
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003091213A1 Novel amide derivatives or salts thereof
11/06/2003WO2003091211A1 Novel heteroaryl compounds
11/06/2003WO2003091207A2 Method of preparing amine stereoisomers
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003090912A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
11/06/2003WO2003090870A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
11/06/2003WO2003090868A1 Method and apparatus for ultrasound treatment of connective tissue
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1564